CRISPR Therapeutics AG Quarterly Other Assets, Noncurrent in USD from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
CRISPR Therapeutics AG quarterly Other Assets, Noncurrent history and growth rate from Q4 2015 to Q3 2024.
  • CRISPR Therapeutics AG Other Assets, Noncurrent for the quarter ending September 30, 2024 was $15.9M, a 676% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $15.9M +$13.8M +676% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $15.1M +$13M +596% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $9.37M +$6.61M +239% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.98M -$2.67M -57.4% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $2.05M -$1.64M -44.4% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $2.18M -$1.59M -42.2% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $2.76M -$1.57M -36.3% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $4.64M -$651K -12.3% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $3.68M -$1.11M -23.1% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $3.76M -$1.8M -32.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $4.33M -$2.17M -33.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $5.29M +$4M +309% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $4.79M +$4.13M +623% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $5.56M +$4.9M +739% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $6.5M +$5.84M +882% Mar 31, 2021 10-Q 2021-04-27
Q4 2020 $1.29M +$196K +17.9% Dec 31, 2020 10-K 2022-02-15
Q3 2020 $662K -$6K -0.9% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $662K -$7K -1.05% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 $662K -$7K -1.05% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $1.1M +$428K +64% Dec 31, 2019 10-K 2021-02-16
Q3 2019 $668K +$18K +2.77% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 $669K -$35K -4.97% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $669K +$98K +17.2% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $669K +$63K +10.4% Dec 31, 2018 10-K 2020-02-12
Q3 2018 $650K -$7K -1.07% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $704K +$467K +197% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $571K +$388K +212% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $606K +$408K +206% Dec 31, 2017 10-K 2019-02-25
Q3 2017 $657K -$3.23M -83.1% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $237K Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $183K Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $198K +$97K +96% Dec 31, 2016 10-K 2018-03-08
Q3 2016 $3.89M Sep 30, 2016 10-Q 2016-11-22
Q4 2015 $101K Dec 31, 2015 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.